 |
Previous Article | Next Article 
Volume 17, Number 19,
Issue of October 1, 1997
pp. 7210-7219
Copyright ©1997 Society for Neuroscience
Rapid Synaptic Transmission in the Avian Ciliary Ganglion Is
Mediated by Two Distinct Classes of Nicotinic Receptors
Erik M. Ullian1,
J. Michael McIntosh2, and
Peter B. Sargent1
1 Neuroscience Graduate Program and Departments of
Stomatology and Physiology, University of California, San Francisco,
California 94143, and 2 Departments of Psychiatry and
Biology, University of Utah, Salt Lake City, Utah 84112
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
We analyzed the kinetics and pharmacology of EPSCs in two kinds of
neurons in the embryonic avian ciliary ganglion. Whole-cell voltage-clamp recordings revealed that the singly innervated ciliary neurons had large-amplitude (1.5-8.0 nA) EPSCs that could be
classified according to the kinetics of their falling phases. Most of
the neurons responded with an EPSC the falling phase of which followed a double exponential time course with time constants of ~1 and 10 msec. The EPSCs of the remaining ciliary neurons followed a single time
constant (~8 msec). Multiple innervated choroid neurons had
smaller-amplitude responses (0.2-1.5 nA when all inputs were activated) that appeared to contain only a slowly decaying component ( = 12 msec). The fast and slow components of EPSC decay seen in
most ciliary neurons could be pharmacologically isolated with two
toxins against nicotinic acetylcholine receptors (AChRs). The fast
component was blocked by 50 nM -bungarotoxin ( -BuTx), which binds 7-subunit-containing AChRs. The slow component was selectively blocked by 50 nM -conotoxin MII
( -CTx-MII), which blocks mammalian AChRs containing an 3/ 2
subunit interface. A combination of both -BuTx and -CTx-MII
abolished nearly all evoked current. Similar pharmacological results
were found for ciliary neurons with monoexponentially decaying EPSCs
and for choroid neurons. These results suggest that nerve-evoked
transmitter acts on at least two different populations of AChRs on
autonomic motor neurons in the ciliary ganglion.
Key words:
acetylcholine receptors;
excitatory postsynaptic current;
-bungarotoxin;
-conotoxin MII;
7;
3;
2
INTRODUCTION
Nicotinic acetylcholine receptors
(AChRs) are a family of ligand-gated oligomeric ion channels assembled
from a pool of 15 or more unique subunits. The application of
recombinant DNA technology has revealed a rich spectrum of AChR subunit
genes expressed by neurons (for review, see Sargent, 1993 ; Decker et
al., 1995 ; McGehee and Role, 1995 ; Lindstrom, 1996 ; Role and Berg,
1996 ; Albuquerque et al., 1997 ). Rapid excitatory synaptic transmission
in autonomic neurons is mediated by AChRs, and autonomic neurons must
therefore make at least one class of receptors that underlie that
function. Many autonomic neurons, however, express mRNAs and gene
products corresponding to several AChR subunits and may be capable of
assembling them into several different oligomeric AChRs (Listerud et
al., 1991 ; Corriveau and Berg, 1993 ; Mandelzys et al., 1995 ). This raises the question of whether these AChRs serve novel roles in addition to their classic role.
We have studied AChR function in parasympathetic motor neurons of the
embryonic chicken ciliary ganglion, in which AChR expression is diverse
and AChRs may serve novel roles. At least five different AChR subunit
genes 3, 5, 7, 2, and 4 are expressed in the ciliary
ganglion, and it is likely that each neuron expresses the full
complement of subunits that is found in the ganglion as a whole (Boyd
et al., 1988 ; Corriveau and Berg, 1993 ). Several studies have
established that neurons in this ganglion express two major classes of
AChRs, one recognized by monoclonal antibody (mAb) 35, known as mAb
35-AChRs, and another recognized by -bungarotoxin ( -BuTx), known
as -BuTx-AChRs (Vernallis et al., 1993 ; Conroy and Berg, 1995 ; Pugh
et al., 1995 ). Within and between these classes there is additional
complexity: most of the mAb 35-AChRs include the 3, 5, and 4
subunits, but a subset of these receptors has, in addition, the 2
subunit (Conroy and Berg, 1995 ). There is also a relatively small
number of receptors that are recognized by both mAb 35 and -BuTx and
apparently are composed of novel AChR subunits (Pugh et al., 1995 ).
Chemical synaptic transmission in the ciliary ganglion is nicotinic
(Martin and Pilar, 1963 ; Dryer, 1994 ) and has been attributed to mAb
35-AChRs rather than -BuTx-AChRs (Smith et al., 1983 ; Halvorsen et
al., 1991 ). -BuTx does not abolish compound action potentials
recorded from the postganglionic nerve in response to preganglionic
nerve stimulation (Chiappinelli and Dryer, 1984 ). Moreover,
-BuTx-AChRs are not concentrated in the synaptic membrane but rather
are extrasynaptic (Jacob and Berg, 1983 ; Loring et al., 1985 ) or, more
precisely, perisynaptic (Wilson Horch and Sargent, 1995 ). mAb 35-AChRs,
on the other hand, are concentrated at synaptic membranes (Jacob et
al., 1984 ; Loring and Zigmond, 1987 ; Wilson Horch and Sargent,
1995 ).
We examined whole-cell currents recorded from ciliary ganglion neurons
of embryonic day 13-16 chicks and found both kinetic and
pharmacological evidence that synaptic transmission is mediated in part
by -BuTx-AChRs. Similar results have been reported recently by Zhang
et al. (1996) . We have extended these findings by (1) analyzing
synaptic currents separately in both ciliary and choroid neurons, which
differ in the sensitivity of their EPSCs to -BuTx, and (2)
dissecting the currents into those sensitive to -BuTx and those
sensitive to the cone snail peptide -conotoxin MII ( -CTx-MII).
-CTx-MII is specific for expressed mammalian AChRs containing an
3/ 2 subunit interface; in the ciliary ganglion -CTx-MII may
block currents that arise from mAb 35-AChRs.
MATERIALS AND METHODS
Chick embryos (Gallus domesticus) were obtained from
Feather Hill Farms (Petaluma, CA). Embryonic day 13-16 chicks were
decapitated, and ciliary ganglia were removed and pinned in a recording
dish with constant flow of oxygenated glucose Ringer's solution. The sheath covering the ganglion was softened with collagenase (4 mg/ml,
type A; Boehringer Mannheim, Indianapolis, IN) applied with pressure
through a 15-30 µm inner diameter pipette and was removed either
with fine forceps or with gentle suction through the pipette (Yawo and
Momiyama, 1992 ). To ensure that the enzyme treatment did not damage the
presynaptic innervation, some ganglia were perfused with oxygenated
glucose Ringer's solution for 1 hr with no enzyme treatment and then
desheathed with fine forceps. There were no statistically significant
differences in EPSC amplitude or kinetics for ciliary neurons examined
from enzyme-treated and untreated ganglia. Neurons were viewed with a
Zeiss 40× water immersion objective (numerical aperture 0.75). The
ganglion was perfused with glucose Ringer's solution containing (in
mM): NaCl 150, KCl 3, CaCl2 2.5 (or 5),
MgCl2 4.5 (or 2), glucose 17, and HEPES 10, pH 7.4. There
was no statistically significant difference in EPSC amplitude or
kinetics in 2.5 and 5.0 mM CaCl2. The pipette solution contained (in mM): CsCl 140, Mg-ATP 2, GTP 0.2, EGTA 2, glucose 5, and HEPES 10, pH 7.2. -BuTx (50-60
nM) was obtained from Biotoxins (St. Cloud, FL).
-CTx-MII was synthesized as described previously (Cartier et al.,
1996 ) and stored either lyophilized or in solution at 4°C.
Whole-cell recording pipettes were pulled from borosilicate glass (WPI,
Sarasota, FL) and had resistances of 1-5 M . Electrodes were coated
with Sigmacote (Sigma, St. Louis, MO). The oculomotor nerve was
stimulated with a suction pipette (0.5-1.0 msec, 5-10 V) at 30-60
sec intervals. Synaptic currents were recorded from cells clamped at
60 mV with an Axopatch-1D amplifier (Axon Instruments, Foster City,
CA), filtered at 2 kHz ( 3 dB, 8-pole Bessel filter), digitized at 25 kHz (TL-1 DMA interface, Axon Instruments), and collected on computer
hard drive with Clampex (pClamp 6.0, Axon Instruments) while input
resistance was continuously monitored. The measured series resistance
(access resistance) was 3-5 M for ciliary neurons and 3-7 M for
choroid neurons. Holding currents necessary to maintain a potential of
60 mV were from 0.01 nA to 0.09 nA. A series compensation of 80%
was typically used. The measured membrane capacitance was 26 ± 4 pF for ciliary neurons and 19 ± 4 pF for choroid neurons,
yielding a calculated time constant with compensation for the clamp
circuit of ~25 µsec. Current records that showed an inflection
during the rising phase of the EPSC were not analyzed further because
of the possibility that they were accompanied by voltage escape.
Experiments were performed at 20-25°C. Toxins were added to the bath
through perfusion or by pipette. Responses were analyzed with Clampfit
and pSTAT (pClamp 6.0, Axon Instruments) and Origin 4.0 (Microcal,
Northhampton, MA) using log maximum-likelihood estimates. Inward
currents are shown as downward deflections but are given positive
values in the text. Curves were fitted from 90% of peak to 10% of
baseline. Samples were compared using the Mann-Whitney test or, if
samples satisfied the normality and equal variance tests, the
Student's t test. All values are given as the mean ± SD.
RESULTS
Neuronal types in the ciliary ganglion
We distinguished ciliary neurons from choroid neurons by three
criteria: cell location, cell body diameter, and number of preganglionic inputs (Dryer and Chiappinelli, 1987 ). Choroid neurons are smaller than ciliary neurons and are located within one quadrant of
the ganglion (Pilar et al., 1980 ; Dryer and Chiappinelli, 1987 ). We
recorded from choroid neurons by pinning the ganglion so that this
quadrant was accessible and by choosing among the smallest neurons
(cell body diameter <20 µm) for recording. We recorded from ciliary
neurons by pinning the ganglion so that the quadrant containing choroid
neurons faced the bottom of the recording chamber and by recording from
larger-diameter neurons (cell body diameter >20 µm). We confirmed
the validity of this selection procedure by noting the number of
independently elicitable synaptic inputs per neuron. Choroid neurons
had a minimum of three synaptic inputs, as judged by the number of
abrupt increments in EPSC size evoked when the stimulus intensity was
progressively increased (n = 15); in contrast, ciliary
neurons each had a single synaptic input (n = 44) (Fig.
1). Another difference between choroid
and ciliary neurons is the size of the EPSC produced by maximal
preganglionic stimulation. Ciliary neurons, which in the embryo have a
single large, calyceal synapse, had large peak EPSC amplitudes, with a
mean amplitude of 4.23 ± 1.81 nA (range, 1.50-8.01 nA). Choroid neurons, which have more conventional synapses and smaller EPSCs than
ciliary neurons (Dryer and Chiappinelli, 1987 ), had a mean peak EPSC
amplitude of 0.75 ± 0.34 nA in response to maximal stimulation of
the preganglionic nerve (range, 0.20-1.47 nA). Thus, the number of
inputs and the peak EPSC amplitude identify ciliary and choroid neurons
as unique cell populations within the ganglion and support the validity
of our identification criteria.
Fig. 1.
Ciliary and choroid neurons can be distinguished
by the extent of synaptic convergence. The two panels show multiple,
superimposed records of evoked synaptic currents recorded from a
ciliary and a choroid neuron. Inward current is represented by a
downward deflection. Preganglionic axons within the oculomotor nerve
were gradually recruited by increasing the stimulus intensity delivered to the nerve via a suction electrode. In the left panel,
a stimulus intensity of 1-3 V caused no synaptic current, whereas a
stimulus of >3 V caused a large synaptic current that fluctuated
little from trial to trial. When the same paradigm was applied to a
choroid neuron, the EPSC increased in several increments, each with a well-defined threshold. The choroid neuron record shows two responses at each of four stimuli, one of which elicited no response. This neuron
had a minimum of three independently elicitable inputs.
[View Larger Version of this Image (12K GIF file)]
Kinetic analysis of EPSCs from ciliary neurons
Most of the ciliary neurons we encountered (28 of 44) had EPSCs
the falling phases of which were not well fit with a single exponential
function. An example of an EPSC from such a neuron is illustrated in
Figure 2A. A semilog
plot of this EPSC (Fig. 2B) shows that the current
decays exponentially with two distinct rates. In this instance, the
digitized EPSC extending from 90% of peak to 10% of baseline was
significantly better fit by the sum of two exponentials than by a
single exponential or by three or more exponentials. The average time
constants for the rapidly and slowly decaying components of the EPSC
were 1.04 ± 0.35 and 11.3 ± 3.3 msec, respectively. The
average fraction of the EPSC amplitude, at 90% of peak, that was
accounted for by the rapidly decaying phase was 41% (range, 20-71%).
The contribution of the rapidly decaying phase is somewhat greater when
the fitted curves are extrapolated back to the time when the EPSC is at
its peak, and it is assumed, for the sake of the calculation, that all
channels open at that time. One explanation for the biexponential decay of the EPSC in these ciliary neurons is that the synaptic current is
generated by the activity of two populations of channels with different
burst duration. Additional evidence for this interpretation will be
provided below, where we describe pharmacological isolation of each
phase of the EPSC.
Fig. 2.
Ciliary neuron EPSC decay is either biexponential
or monoexponential. A, A biexponential ciliary EPSC. The
EPSC falling phase was best fit with two exponentials as assessed by
the maximum-likelihood estimation method (pClamp 6.0).
B, The EPSC replotted in semilogarithmic coordinates.
The two exponential components can be seen qualitatively as linear
phases of the current decay. C, A monoexponential
ciliary EPSC. The falling phase of the EPSC was best fit with a single exponential. D, The EPSC replotted in semilogarithmic
coordinates. The single exponential component can be seen qualitatively
as a linear phase.
[View Larger Version of this Image (19K GIF file)]
Not all ciliary neurons had EPSCs that decayed biexponentially. Figure
2C,D shows an example of a record the falling phase of which
is best fit by a single exponential with a time constant of 7.81 msec.
The average time constant of decay of the monoexponential EPSCs was
8.25 ± 2.03 msec, a number similar to the slow component of the
biexponentially decaying EPSC (11.3 msec). Ciliary neurons with a
single component of EPSC decay are not likely to be damaged as compared
with neurons with a two-component EPSC; we found no difference between
these two populations of recordings with regard to seal resistance,
input resistance, or the amount of current needed to hold the membrane
potential at 60 mV (data not shown). Are these neurons qualitatively
different from those with biexponentially decaying EPSCs, or do they
simply represent a subset of cells with a rapidly decaying EPSC
component that is too small to detect? To assess how much rapidly
decaying current must be present for detection, we generated a family
of biexponential curves with time constants of 1.1 and 11.0 msec and
with a variable amount of fast component (measured at 90% of the
peak), and then we determined how much of the fast component must be
present before it is detected by the pSTAT program. The program
detected a rapidly decaying component only if >13% of the peak
current was "fast." Interestingly, this is also approximately the
amount of fast component needed for the eye to readily detect a
biexponential trace. Thus, it is possible that a small rapidly decaying
component of synaptic current may be present in ciliary neurons that
appear to have monoexponentially decaying EPSCs.
To learn whether monoexponential and biexponential EPSCs represent two
extremes of a continuous population, we subjected all EPSC decays to
the curve-fitting procedure assuming two components, and we then
plotted the fraction of the total current attributable to the rapidly
decaying component as a cumulative frequency distribution. For 13 of
the 16 apparently monoexponentially decaying EPSCs, the pCLAMP
curve-fitting program produced a trivial second component of EPSC decay
(e.g., with an amplitude of 10 5 nA), and we
assumed that there was no rapidly decaying component in these
recordings. For the three remaining apparently monoexponential recordings, the pCLAMP program assigned a small component of rapidly decaying current, amounting to 3-5% of the total. A cumulative frequency distribution for the fraction of EPSC that is fast for all 44 ciliary neurons (Fig. 3) shows a
discontinuity: 36% of the neurons (16/44) have EPSCs with <5% of the
current decaying rapidly, whereas 64% of the neurons (28/44) have
EPSCs with >20% of the current decaying rapidly, but no neurons have
EPSCs with intermediate values (5-20%). This suggests that the two
populations of neurons characterized as biexponential or
monoexponential are distinct. Another finding that supports this
interpretation is that the time constants for EPSC decay for the slow
component of "biexponential" neurons and for the only component of
"monoexponential" neurons are significantly different (Fig.
4) (means of 11.3 ± 3.3 and
8.25 ± 2.03 msec, respectively; p = 0.016 by
Student's t test, which in this instance had a power of
0.62, below the desired power of 0.80). Could the difference in time
constant have arisen artifactually as the result of a systematic error in the curve-fitting procedure? Probably not: the algorithm is able to
estimate to within 1% accuracy the time constant for the slowly
decaying phase when asked to analyze families of theoretical curves in
which a slow phase is mixed with varying amounts of a fast phase (not
shown). The amplitude of the two components was similar (3.01 ± 1.32 and 2.92 ± 0.84 nA at 90% of peak; p = 0.88 by Mann-Whitney rank sum test). Thus, monoexponential ciliary neurons
appear to be qualitatively different from neurons the EPSCs of which
decay with two exponentials by two criteria: (1) differences in the
fraction of the EPSC that is rapidly decaying and (2) differences in
the time constant of decay for the slow phase. The difference in the
time constants for these two populations implies that the burst
duration for the underlying channels is different.
Fig. 3.
The cumulative distribution of the relative amount
of rapidly decaying current in ciliary EPSCs suggests two distinct
ciliary neuron populations. All ciliary neuron EPSCs were fitted
assuming two phases of decay, and the ratio of the amplitude of the
fast component to the total current (at 90% of peak) is displayed in a
cumulative distribution plot. The plot shows a break in the distribution of amplitude ratios, with one group showing 20% or more
of the fast component and another group showing 5% or less of the fast
component.
[View Larger Version of this Image (23K GIF file)]
Fig. 4.
The time constant of decay for the slow phase of
biexponential ciliary neurons differs from that of monoexponential
ciliary neurons. Shown is a cumulative probability plot of the slow
component of decay of biexponential ciliary EPSCs and the single
component of decay of monoexponential ciliary EPSCs. The two
populations of are significantly different
(p = 0.016 by Student's t
test). This indicates that the biexponential and monoexponential
neurons constitute two distinct classes of neurons, on the basis of the time constant of the slow phase of decay.
[View Larger Version of this Image (24K GIF file)]
Ciliary neurons having little or no rapidly decaying EPSC component
(i.e., "monoexponentials") accounted for 36% of neurons in the
sample we encountered; however, this may not reflect the actual
fraction of these neurons within the ganglion, because we recorded only
from neurons at selected parts of the periphery of the ganglion. Our
results are consistent with there being comparable numbers of the two
types of neurons in the ganglion.
Pharmacology of ciliary EPSCs
We isolated each component of ciliary EPSCs pharmacologically with
the use of the neurotoxins -BuTx and -CTx-MII. Within the ciliary
ganglion, 95% of AChRs recognized by -BuTx contain 7 subunits
(Pugh et al., 1995 ), whereas -CTx-MII is specific, among
heterologously expressed mammalian AChRs, for 3 2 AChRs (Cartier
et al., 1996 ). As illustrated in Figure
5A, 50 nM -BuTx reduced the peak amplitude of the EPSC and had less effect on the
slowly decaying phase of the current (Fig. 5A, semilog
trace). In all three instances when -BuTx was added to the bath
while we recorded from a "biexponential" ciliary neuron, the EPSC
was reduced to a single component of decay with a time course
indistinguishable from that of the slow component present before
addition of the toxin ( = 13.7 ± 4.1 msec before and 11.8 ± 5.3 msec after toxin; p = 0.65 by paired Student's
t test). The amplitude of the slowly decaying component was
reduced by ~50% from that present before the addition of toxin
(amplitude at 90% of peak = 2.62 ± 0.88 nA before and
1.30 ± 0.55 nA after; p = 0.005 by paired
t test). In control experiments in which we maintained
whole-cell recordings for 45 min, the longest duration of a toxin
experiment, we saw only a modest loss in amplitude of the EPSC or of
either of its components (3-10%; n = 4).
Fig. 5.
Effect of 50 nM -BuTx
(A) and 50 nM -CTx-MII
(B) on ciliary neuron biexponential EPSCs. The
left trace in both A and B
shows the EPSC from a ciliary neuron recorded before toxin addition. The middle trace shows the EPSC of the same cell after
stabilization of the toxin effect. The right trace shows
the semilog plots of the before- and after-toxin EPSCs. The rapidly
decaying phase of current is eliminated by -BuTx, whereas the slowly
decaying phase is eliminated by -CTx-MII.
[View Larger Version of this Image (21K GIF file)]
In four experiments in which we recorded from neurons in 200 nM rather than 50 nM -BuTx, we found no
statistically significant difference between the amplitude or time
course of EPSCs recorded at these two concentrations
(p = 0.34; Student's t test).
Therefore, 50 nM -BuTx has a maximal effect on both the
fast and slow time course of the synaptic current.
The effects of -BuTx on ciliary neuron EPSCs were not readily
reversible. In two experiments we were able to hold neurons for at
least 30 min after toxin washout, and in each instance there was no
measurable return of the rapidly decaying response nor was there an
increase in the size of the slowly decaying response. -BuTx begins
to have an effect within 5 min of its addition to the bath, and so the
failure to see a recovery is presumably attributable to the fact that
the toxin remains bound to its receptor.
-CTx-MII had an effect on biexponentially decaying ciliary neuron
EPSCs that was complementary to that of -BuTx. Figure 5B
shows an example of the effects of 50 nM -CTx-MII on a
biexponentially decaying EPSC of a ciliary neuron. The toxin altered
the trace to a monoexponentially decaying one, with a time constant of
decay similar to that of the rapidly decaying component present
beforehand; similar results were found in each of four other
experiments. A comparison of the properties of the rapidly decaying
phase before and after -CTx-MII suggests that its amplitude is
unchanged (90% of peak = 1.88 ± 1.01 and 2.15 ± 1.00 nA, respectively; p = 0.18 by paired t test)
but that its time constant is increased (from 1.16 ± 0.35 to
1.88 ± 0.34 msec; p = 0.019 by paired
t test). We believe, however, that this increase is only
apparent and is the result of inaccuracies in the curve-fitting
procedure. Thus, when we construct artificial biexponentially decaying
curves with 90% or more fast current ( =1.2 msec) and 10% or less
slow current ( =12.0 msec), the Clampfit curve-fitting algorithm,
which examines the curve from 90% of peak to 10% of baseline,
sometimes overestimates the time constant for the rapidly decaying
component by up to 75% (yielding, for example, 1.8 msec for a
component that actually decays at 1.2 msec). This can be understood by
assuming that the program is unable to separate completely the two
phases of decay and has "contaminated" the rapid phase with the
slower phase. This was a problem only with curves with large amounts of
rapidly decaying current and small amounts of slowly decaying current, and not vice versa.
The use of higher concentrations of -CTx-MII (200 nM)
did not reduce the amplitude of the rapidly decaying component (data not shown). There was also no difference in the time course of EPSCs
recorded in 50 nM versus 200 nM -CTx-MII
(p = 0.7 by Student's t test). This
implies that -CTx-MII, like -BuTx, has a maximal effect by 50 nM.
Application of 50 nM -CTx-MII followed by 50 nM -BuTx blocked the ciliary neuron EPSC nearly
completely (Fig. 6) (similar results were
seen in two other experiments). This demonstrates that nicotinic AChRs
sensitive to either -BuTx or -CTx-MII account for nearly all the
synaptic current elicited from some ciliary neurons by nerve-released
transmitter. In one ganglion we detected very small (0.06 nA) currents
in two of five neurons examined in the presence of both 200 nM -BuTx and 200 nM -CTx-MII (data not
shown). This represents 1.4% of the peak current of the average ciliary EPSC. It is possible that some neurons contain a
small-amplitude current insensitive to both toxins, but we cannot rule
out trivial explanations, such as incomplete access of the toxins to
all synaptic sites.
Fig. 6.
-CTx-MII and -BuTx together block the
ciliary EPSC. The left panel shows a biexponential
ciliary EPSC, the middle panel shows the EPSC of the
same cell after addition of 50 nM -CTx-MII, and the
right panel shows the EPSC of the same cell after
further addition of 50 nM -BuTx.
[View Larger Version of this Image (10K GIF file)]
The effect of -BuTx and -CTx-MII on biexponentially decaying
ciliary neuron EPSCs suggests that -BuTx blocks the rapidly decaying
component and a fraction of the slowly decaying component of current,
whereas -CTx-MII blocks the slowly decaying component of the
current. In a few experiments we tested the effects of these toxins on
monoexponentially decaying ciliary EPSCs and found that this current
behaved pharmacologically like the slowly decaying component of
biexponential EPSCs. Figure
7A shows an example: -BuTx
reduced the peak by ~50% but did not affect the time constant of
decay. In three experiments we found a significant reduction in the
amplitude of the response (2.43 ± 1.03 vs 1.27 ± 0.71 nA; p = 0.044 by paired t test) without a
significant effect on the time constant of decay (6.73 ± 0.84 vs
7.93 ± 2.67 msec; p = 0.4 by paired t
test). This argues that the slowly decaying components of the EPSC in
"biexponential" and "monoexponential" ciliary neurons are
pharmacologically similar, despite that fact that the time constants of
their decay are different.
Fig. 7.
Effect of 50 nM -BuTx
(A) and 50 nM -CTx-MII
(B) on ciliary neuron monoexponential EPSCs. See
legend to Figure 5 for complete description of traces. -BuTx reduces
the peak of the EPSC but does not change its time course of decay
(A). -CTx-MII reduces the EPSC size
substantially, eliminates the slowly decaying phase of current, and
reveals a small, rapidly decaying phase of current (B).
[View Larger Version of this Image (21K GIF file)]
-CTx-MII had an effect on monoexponentially decaying ciliary EPSCs
quite different from that of -BuTx. Figure 7B shows an example in which 50 nM -CTx-MII reduced the amplitude of
the EPSC drastically; the surviving current had a decay considerably more rapid than that recorded beforehand. In six experiments we found a
pronounced effect on the amplitude of the monoexponentially decaying
ciliary EPSCs (from 3.30 ± 1.60 to 0.62 ± 0.19 nA;
p = 0.03 by paired t test) and a significant
change in the time constant of decay (from 9.4 ± 1.6 to 1.5 ± 0.5 msec; p = 0.0002 by paired t test).
These results are consistent with the suggestion that ciliary EPSCs
that appear to decay monoexponentially do indeed have a minor component
of rapidly decaying current that is too small to detect by
curve-fitting procedures but that can be unveiled with -CTx-MII.
-BuTx may reduce the amplitude of these currents by eliminating the
rapidly decaying component as well as some of the slowly decaying
component.
Choroid neuron EPSC kinetics and pharmacology
Choroid neurons are distinct from ciliary neurons by having
multiple inputs as many as six. Because some of these inputs are small
and produced EPSCs that fluctuated from trial to trial, we
analyzed the kinetics and pharmacology of choroid neuron EPSCs by
eliciting release from all preganglionic inputs simultaneously via
maximal stimulation of the preganglionic nerve.
The decaying phase of choroid EPSCs was best described by a single
exponential function in all instances (n = 15) (Fig.
8). The time constant describing the
decay of choroid neuron EPSCs, 11.8 ± 2.0 msec, was similar to
that for the slow phase of EPSC decay for biexponential ciliary neurons
(p = 0.81 by Student's t test) but
was significantly different from the corresponding value for
monoexponentially decaying ciliary neuron EPSCs
(p = 0.005 by Student's t test).
Fig. 8.
Choroid neuron EPSCs are best fit with a
single exponential. The left trace shows a choroid EPSC.
The right trace shows the same EPSC replotted in semilog
coordinates. All choroid EPSCs examined (n = 15)
were best fit with a single exponential.
[View Larger Version of this Image (10K GIF file)]
The pharmacological sensitivity of choroid neurons to -BuTx and
-CTx-MII was similar to that of monoexponential ciliary EPSCs.
Figure 9A shows an example of
the effects of 50 nM -BuTx on a choroid neuron EPSC. The
peak response is reduced somewhat, with little effect on the decay
phase of the current. In three experiments, 50 nM -BuTx
reduced the amplitude of the EPSC (from 0.92 ± 0.38 to 0.34 ± 0.16 nA; p = 0.047 by paired t test) but had no significant effect on the time constant of EPSC decay (12.8 ± 3.5 to 14.4 ± 2.3 nA; p = 0.12 by paired
t test). By contrast, -CTx-MII had a profound effect on
choroid neuron EPSCs. Figure 9B shows an example in which 50 nM -CTx-MII reduced the peak amplitude by well over
50%; in four experiments 50 nM -CTx-MII reduced the
peak response by 84% (0.98 ± 0.56 to 0.12 ± 0.09 nA; p = 0.04 by t test). The small component of
-CTx-MII-resistant current decayed rapidly but was too small to
permit us to measure its time constant accurately. The effects of
-BuTx and -CTx-MII on choroid neuron EPSCs can be understood by
assuming that like monoexponential ciliary EPSCs, choroid EPSCs contain
a major component of slowly decaying current completely sensitive to
-CTx-MII and partially sensitive to -BuTx and a minor component
of rapidly decaying current sensitive to -BuTx.
Fig. 9.
Effect of 50 nM -BuTx
(A) and 50 nM -CTx-MII
(B) on choroid neuron EPSCs. See legend to Figure
5 for complete description of traces. -BuTx reduces the peak of the
EPSC but does not change the rate of decay (A).
-CTx-MII substantially reduces the EPSC size, eliminates the slowly
decaying phase of current, and reveals a small, rapidly decaying phase
of current (B).
[View Larger Version of this Image (20K GIF file)]
DISCUSSION
We have analyzed the kinetics and pharmacology of EPSCs from
ciliary ganglion neurons. Most of the ciliary neurons that we sampled
had EPSCs that decayed biexponentially, with time constants of ~1 and
10 msec. The rapidly decaying component of the EPSC was completely
blocked by -BuTx, whereas the slowly decaying component was
partially blocked by -BuTx and completely blocked by -CTx-MII.
The remainder of the ciliary neurons, and all sampled choroid neurons,
had EPSCs that appeared to be monoexponential, having a time constant
of ~10 msec; however, pharmacological evidence suggests that these
neurons also had rapidly and slowly decaying components, with
sensitivity to -BuTx and -CTx-MII similar to that of their
biexponential counterparts. These findings complement the recent
results of Zhang et al. (1996) , who reported on the dual nature of EPSC
decay of an unselected population of ciliary ganglion neurons and on
the sensitivity of the rapidly decaying component of EPSC to
-BuTx.
The two components of EPSC decay probably represent the behavior of
different populations of AChR channels. If transmitter is present
briefly in the synaptic cleft, such that no channels open for the first
time during the falling phase of the EPSC, then the principal
determinant of EPSC falling phase should be the channel burst duration.
This implies that nerve-released ACh has access to at least two
populations of receptor-channel complexes, and this interpretation is
borne out by the pharmacological data.
Four populations of ACh channels have been detected on neurons cultured
from embryonic day 14 ciliary ganglion, with conductances of 25, 40, 60, and 80 pS (Margiotta and Gurantz, 1989 ; J. Margiotta, personal
communication). The open lifetime histograms for the 25 and 40 pS
channels were dominated by events having mean open times of ~1 msec,
whereas the 60 and 80 pS events were briefer (0.1-0.3 msec). The 60 and 80 pS events are abolished by -BuTx (J. Margiotta, personal
communication), suggesting that they may underlie the rapidly decaying
component of the EPSC, whereas the 25 and 40 pS events may underlie the
slowly decaying component of the EPSC. The difference between the mean
open times and the EPSC decay time constants may reflect differences in
the lifetimes of individual channel openings versus bursts of openings
contributing to the falling phase of the EPSC.
The fast component of current decay is likely caused by 7 AChR,
because of both its rapid time course and its sensitivity to -BuTx
(Couturier et al., 1990 ; Anand et al., 1993 ; Zhang et al., 1994 ; Pugh
et al., 1995 ). 7-containing AChRs are abundant in the ciliary
ganglion (Conroy and Berg, 1995 ), and all ganglion neurons express
-BuTx receptors (Jacob and Berg, 1983 ; Wilson Horch and Sargent,
1995 ). If the 20 fmol of -BuTx AChRs in the ganglion (Conroy and
Berg, 1995 ) were distributed evenly and exclusively among its 3000 neurons, then each neuron would have ~4 × 106 receptors. If we take 70 pS as an open channel
conductance for these receptors (see above), then the single channel
current would be ~4 pA with a driving force of 60 mV. Only a few
thousand such receptors, if activated synchronously, would be needed to
produce the -BuTx-sensitive component observed.
-BuTx at 50 nM blocked most of the rapidly decaying EPSC
and about half of the slowly decaying EPSC from biexponential ciliary neurons. Incomplete block of the slowly decaying current is not likely
to have resulted from a partial occupancy of a low-affinity AChR,
because the block was not enhanced at 200 nM -BuTx.
These data are consistent with the existence of two populations of
-BuTx-sensitive AChRs, one of which is also sensitive to
-CTx-MII. No known AChR subunit combination is sensitive to both
-BuTx and -CTx-MII, including 7 homo-oligomers and
x y hetero-oligomers in which x = 2, 3, or 4, and y = 2 or 4 (Johnson
et al., 1995 ; Cartier et al., 1996 ). Perhaps 7-containing AChRs in
the ganglion include both homo-oligomers, which presumably underlie the
rapidly decaying EPSC component, and hetero-oligomers (Listerud et al.,
1991 ); however, immunochemical studies (Vernallis et al., 1993 ; Conroy and Berg, 1995 ) have not found a detectable association between 7
subunits and other identified AChR subunits in the ganglion ( 3,
5, 2, or 4). Another possibility is that the AChRs that underlie the -BuTx-sensitive, slowly decaying EPSC are those recently identified by Pugh et al. (1995) that are recognized by
-BuTx but have neither 7 nor any of the other AChR subunit gene
products identified in the ganglion.
-CTx-MII is selective for 3 2 AChRs among mammalian types
expressed in oocytes (Cartier et al., 1996 ) and may be blocking an AChR
containing these subunits in the ciliary ganglion, given the high
degree of homology between rat and chicken sequences (70-90% at the
amino acid level). The 3 and 2 subunits are both present in the
ciliary ganglion (Vernallis et al., 1993 ; Conroy and Berg, 1995 ), and
immunoreactivity corresponding to both subunits is expressed in all
neurons within the ganglion (H. L. Wilson Horch and P. B. Sargent, unpublished observations). Vernallis et al. (1993) and Conroy
and Berg (1995) have found that all AChRs in extracts of the ganglion
that contain immunoreactivity corresponding to the 3 and the 2
subunits also contain the 5 and 4 subunits. This suggests that
the target for -CTx-MII may be an AChR oligomer with four different
subunits.
Our pharmacological results on biexponential ciliary neurons are
generally similar to those of Zhang et al. (1996) . One difference is
that we find that 50 nM -BuTx has a more modest effect
on peak EPSCs: the average reduction in the peak of the biexponential EPSC was 71% in our experiments and 92% in theirs. A second
difference, which might be explained by differences in sampling, is
that we found both neurons with biexponential EPSC decays and those
with monoexponential decays, whereas Zhang et al. (1996) reported
finding only neurons with biexponential decays. Finally, our time
constants for the two phases of EPSC decay for the biexponential
ciliary neurons were briefer than theirs (1.0 and 11.3 msec vs 2.3 and 23.9 msec). Other than possible sampling differences, we can identify no obvious experimental differences between the protocol used by the
two labs, or in the species or age of animals examined, that can
explain these differences.
The two populations of ciliary neurons identified on the basis of their
EPSC kinetics seem to differ both in the relative amount of "slow"
and "fast" AChRs to which transmitter has access and possibly in
the properties of the "slow" AChR channels, given that their burst
durations are different. Subpopulations of ciliary neurons can be
identified by differences in their projections (Pilar et al., 1980 ).
Conceivably, neurons that project to different peripheral sites have
distinct modes of transmission, perhaps because of differences in
retrograde signals.
How many distinct AChR classes underlie the currents recorded from
embryonic ciliary and choroid neurons? If each pharmacologically and
kinetically distinct population of channel openings were to represent a
unique AChR, then there might be as many as five AChR populations
differing in subunit composition and post-translational modification:
three in ciliary neurons [(1) rapidly decaying, -BuTx sensitive,
-CTx-MII resistant; (2) slowly decaying, -BuTx sensitive,
-CTx-MII sensitive; and (3) slowly decaying, -BuTx resistant, and
-CTx-MII sensitive] and two additional populations in choroid
neurons (both -CTx-MII sensitive but differing in their resistance
to -BuTx). The argument that the two components of current in
choroid neurons represent AChRs distinct from their ciliary
counterparts rests on their slower decay rates. Although the difference
in decay rate is statistically significant, it is moderate (25%) and
may not "bear up" under further scrutiny.
The realization that -BuTx-sensitive AChRs underlie a significant
component of synaptic current in many ciliary neurons comes as a
surprise. For one, Chiappinelli and Dryer (1984) found that -BuTx
did not block postganglionic compound action potentials. This is
apparently because the synaptic currents recorded in the presence of
-BuTx are still sufficient to reach threshold (Zhang et al., 1996 ).
The role of -BuTx-AChRs in rapid transmission also is unexpected in
light of the established location of these AChRs, which are principally
perisynaptic (Jacob and Berg, 1983 ; Loring et al., 1985 ; Wilson Horch
and Sargent, 1995 ). Is it possible that nerve-released transmitter
diffuses to these perisynaptic sites and activates AChRs there? This
scenario is feasible, given that the diffusion equation predicts that
nerve-released transmitter can reach regions within 2 µm of the
release site in 1-2 msec. The rapid rise and fall of the synaptic
current that is sensitive to -BuTx suggests that the AChRs
underlying this current are activated fairly synchronously. This might
be assured if these receptors, although extrasynaptic, are a consistent
distance from release sites. Another possibility is that there are
-BuTx-AChRs postsynaptically in numbers too small to be readily
detected. Perhaps only a few thousand -BuTx-AChRs need to be
activated to produce the synaptic currents noted by us and by Zhang et
al. (1996) , and yet the presence of 20 fmol of -BuTx-AChRs per
ganglion may translate into a million AChRs per neuron. The small
numbers of putative synaptic -BuTx-AChRs might be nearly
undetectable if they are distributed among the many active zones
present on a single ciliary neuron. Zhang et al. (1996) reported that
the addition of an acetylcholinesterase inhibitor did not enhance or
prolong the -BuTx-sensitive synaptic current (although it did
enhance the -BuTx-insensitive currents). This suggests either that
there is no acetylcholinesterase present within the synaptic cleft, a
notion that conflicts with histochemical data (Fumagalli et al., 1982 ),
or that the -BuTx-AChRs are saturated by nerve-released transmitter.
Because it is difficult to imagine that nerve-released ACh could
saturate a large number of extrasynaptic AChRs, perhaps the
-BuTx-sensitive current may be produced when transmitter activates
and saturates small synaptic clusters of -BuTx-AChRs. Inhibition of
acetylcholinesterase might not enhance synaptic currents if
perisynaptic -BuTx-AChRs desensitize before opening or if they are
nonfunctional (Margiotta et al., 1987 ).
Why should there be two separate classes of AChRs underlying
rapid synaptic transmission? The explanation seems not to be a
meaningful increase in safety factor, because either receptor class
alone provides for transmission with high reliability (Zhang et al.,
1996 ). One intriguing possibility is that the two AChR classes are
activated by different, physiologically relevant trains of stimuli. An
additional possibility is that the high calcium permeability of the
-BuTx-AChRs (Vijayaraghavan et al., 1992 ; Vernino et al., 1994 ) will
prove to be meaningful: perhaps activation of these AChRs turns on a
calcium-dependent second messenger system that is important for the
maintenance of synaptic efficacy.
FOOTNOTES
Received May 6, 1997; revised July 8, 1997; accepted July 10, 1997.
This work was supported by National Institutes of Health Grants NS
24207, GM 07449, MH 53631, and GM48677. We thank Drs. J. Margiotta, B. Walmsley, and D. Yoshikami for critically reading a draft of this
manuscript; Drs. P. Castillo, S. E. Dryer, P. Hickmott, P. H. Steen, M. Weisskopf, and H. Yawo for advice; and Ms. Evangeline Leash
for editorial assistance.
Correspondence should be addressed to Dr. Peter B. Sargent, Division of
Oral Biology, HSW-604, University of California, San Francisco, CA
94143-0512.
REFERENCES
-
Albuquerque EX,
Alkondon M,
Pereira EF,
Castro NG,
Schrattenholz A,
Barbosa CT,
Bonfante-Cabarcas R,
Aracava Y,
Eisenberg HM,
Maelicke A
(1997)
Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function.
J Pharmacol Exp Ther
280:1117-1136[Free Full Text].
-
Anand R,
Peng X,
Lindstrom J
(1993)
Homomeric and native alpha7 acetylcholine receptors exhibit remarkably similar but non-identical pharmacological properties, suggesting that the native receptor is a heteromeric protein complex.
FEBS Lett
327:241-246[Web of Science][Medline].
-
Boyd RT,
Jacob MH,
Couturier S,
Ballivet M,
Berg DK
(1988)
Expression and regulation of neuronal acetylcholine receptor mRNA in chick ciliary ganglia.
Neuron
1:495-502[Web of Science][Medline].
-
Cartier GE,
Yoshikami DJ,
Gray WR,
Luo SQ,
Olivera BM,
McIntosh JM
(1996)
A new alpha-conotoxin which targets alpha-3-beta-2 nicotinic acetylcholine receptors.
J Biol Chem
271:7522-7528[Abstract/Free Full Text].
-
Chiappinelli VA,
Dryer SE
(1984)
Nicotinic transmission in sympathetic ganglia: blockade by the snake venom neurotoxin kappa-bungarotoxin.
Neurosci Lett
50:239-244[Web of Science][Medline].
-
Conroy WG,
Berg DK
(1995)
Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions.
J Biol Chem
270:4424-4431[Abstract/Free Full Text].
-
Corriveau RA,
Berg DK
(1993)
Coexpression of multiple acetylcholine receptor genes in neurons: quantification of transcripts during development.
J Neurosci
13:2662-2671[Abstract].
-
Couturier S,
Bertrand D,
Matter J-M,
Hernandez M-C,
Bertrand S,
Millar N,
Valera S,
Barkas T,
Ballivet M
(1990)
A neuronal nicotinic acetylcholine receptor subunit (alpha7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX.
Neuron
5:847-856[Web of Science][Medline].
-
Decker MW,
Brioni JD,
Bannnon AW,
Americ SP
(1995)
Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics.
Life Sci
56:545-570[Web of Science][Medline].
-
Dryer SE
(1994)
Functional development of the parasympathetic neurons of the avian ciliary ganglion: a classic model system for the study of neuronal differentiation and development.
Prog Neurobiol
43:281-322[Web of Science][Medline].
-
Dryer SE,
Chiappinelli VA
(1987)
Analysis of quantal content and quantal conductance in two populations of neurons in the avian ciliary ganglion.
Neuroscience
20:905-909[Web of Science][Medline].
-
Fumagalli L,
Del Fa A,
Olivieri-Sangiacomo C
(1982)
Surface AChE in the chick ciliary ganglion neurons: ultrastructural localization and possible relations to
-bungarotoxin receptors.
Neurochem Int
4:15-21. -
Halvorsen SW,
Schmid HA,
McEachern AE,
Berg DK
(1991)
Regulation of acetylcholine receptors on chick ciliary ganglion neurons by components from the synaptic target tissue.
J Neurosci
11:2177-2186[Abstract].
-
Jacob MH,
Berg DK
(1983)
The ultrastructural localization of alpha-bungarotoxin binding sites in relation to synapses on chick ciliary ganglion neurons.
J Neurosci
3:260-271[Abstract].
-
Jacob MH,
Berg DK,
Lindstrom JM
(1984)
Shared antigenic determinants between Electrophorus acetylcholine receptor and a synaptic component on chicken ciliary ganglion neurons.
Proc Natl Acad Sci USA
81:3223-3227[Abstract/Free Full Text].
-
Johnson DS,
Martinez J,
Elgoyhen AB,
Heinemann SF,
McIntosh JM
(1995)
-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric 7 and 9 receptors.
Mol Pharmacol
48:194-199[Abstract]. -
Lindstrom J
(1996)
Neuronal nicotinic acetylcholine receptors.
In: Ion channels (Narahashi T,
ed), pp 377-450. New York: Plenum.
-
Listerud M,
Brussard AB,
Kevay P,
Colman DR,
Role LW
(1991)
Functional contribution of neuronal AChR subunits by antisense oligonucleotides.
Science
254:1518-1521[Abstract/Free Full Text].
-
Loring RH,
Zigmond RE
(1987)
Ultrastructural distribution of 125I-toxin F binding sites on chick ciliary neurons: synaptic localization of a toxin that blocks ganglionic nicotinic receptors.
J Neurosci
7:2153-2162[Abstract].
-
Loring RH,
Dahm LM,
Zigmond RE
(1985)
Localization of alpha-bungarotoxin binding sites in the ciliary ganglion of the embryonic chick: an autoradiographic study at the light and electron microscopic level.
Neuroscience
14:645-660[Web of Science][Medline].
-
Mandelzys A,
Dekininck P,
Cooper E
(1995)
Agonist and toxin sensitivities of ACh-evoked currents on neurons expressing multiple nicotinic ACh receptor subunits.
J Neurophysiol
74:1212-1221[Abstract/Free Full Text].
-
Margiotta JF,
Gurantz D
(1989)
Changes in the number, function, and regulation of nicotinic acetylcholine receptors during neuronal development.
Dev Biol
135:326-339[Web of Science][Medline].
-
Margiotta JF,
Berg DK,
Dionne VE
(1987)
The properties and regulation of functional acetylcholine receptors on chick ciliary ganglion neurons.
J Neurosci
7:3612-3622[Abstract].
-
Martin AR,
Pilar G
(1963)
Transmission through the ciliary ganglion of the chick.
J Physiol (Lond)
168:464-475.
-
McGehee DS,
Role LW
(1995)
Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons.
Annu Rev Physiol
57:521-546[Web of Science][Medline].
-
Pilar G,
Landmesser L,
Burstein L
(1980)
Competition for survival among developing ciliary ganglion cells.
J Neurophysiol
43:233-254[Abstract/Free Full Text].
-
Pugh PC,
Corriveau RA,
Conroy WG,
Berg DK
(1995)
Novel subpopulation of neuronal acetylcholine receptors among those binding alpha-bungarotoxin.
Mol Pharmacol
47:717-725[Abstract].
-
Role LW,
Berg DK
(1996)
Nicotinic receptors in the development and modulation of CNS synapses.
Neuron
16:1077-1085[Web of Science][Medline].
-
Sargent PB
(1993)
The diversity of neuronal nicotinic acetylcholine receptors.
Annu Rev Neurosci
16:403-443[Web of Science][Medline].
-
Smith MA,
Margiotta JF,
Berg DK
(1983)
Differential regulation of acetylcholine sensitivity and
-bungarotoxin-binding sites on ciliary ganglion neurons in cell culture.
J Neurosci
3:2395-2402[Abstract]. -
Vernallis AB,
Conroy WG,
Berg DK
(1993)
Neurons assemble acetylcholine receptors with as many as three kinds of subunits while maintaining subunit segregation among receptor subtypes.
Neuron
10:451-464[Web of Science][Medline].
-
Vernino S,
Rogers M,
Radcliffe KA,
Dani JA
(1994)
Quantitative measurement of calcium flux through muscle and neuronal nicotinic acetylcholine receptors.
J Neurosci
14:5514-5524[Abstract].
-
Vijayaraghavan S,
Pugh PC,
Zhang Z-W,
Rathouz MM,
Berg DK
(1992)
Nicotinic receptors that bind alpha-bungarotoxin on neurons raise intracellular free Ca2+.
Neuron
8:352-363.
-
Wilson Horch HL,
Sargent PB
(1995)
Perisynaptic surface distribution of multiple classes of nicotinic acetylcholine receptors on neurons in the chicken ciliary ganglion.
J Neurosci
15:7778-7795[Abstract].
-
Yawo H,
Momiyama A
(1992)
Re-evaluation of calcium currents in pre- and postsynaptic neurons of the chick ciliary ganglion.
J Physiol (Lond)
460:153-172[Abstract/Free Full Text].
-
Zhang Z,
Coggan J,
Berg D
(1996)
Synaptic currents generated by neuronal acetylcholine receptors sensitive to alpha-bungarotoxin.
Neuron
17:1231-1240[Web of Science][Medline].
-
Zhang Z-W,
Vijayaraghavan S,
Berg DK
(1994)
Neuronal acetylcholine receptors that bind
-bungarotoxin with high affinity function as ligand-gated ion channels.
Neuron
12:167-177[Web of Science][Medline].
This article has been cited by other articles:

|
 |

|
 |
 
P. B. Sargent
Nicotinic Receptors Concentrated in the Subsynaptic Membrane Do Not Contribute Significantly to Synaptic Currents at an Embryonic Synapse in the Chicken Ciliary Ganglion
J. Neurosci.,
March 25, 2009;
29(12):
3749 - 3759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Razani-Boroujerdi, R. T. Boyd, M. I. Davila-Garcia, J. S. Nandi, N. C. Mishra, S. P. Singh, J. C. Pena-Philippides, R. Langley, and M. L. Sopori
T Cells Express {alpha}7-Nicotinic Acetylcholine Receptor Subunits That Require a Functional TCR and Leukocyte-Specific Protein Tyrosine Kinase for Nicotine-Induced Ca2+ Response
J. Immunol.,
September 1, 2007;
179(5):
2889 - 2898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rassadi, A. Krishnaswamy, B. Pie, R. McConnell, M. H. Jacob, and E. Cooper
A Null Mutation for the {alpha}3 Nicotinic Acetylcholine (ACh) Receptor Gene Abolishes Fast Synaptic Activity in Sympathetic Ganglia and Reveals That ACh Output from Developing Preganglionic Terminals Is Regulated in an Activity-Dependent Retrograde Manner
J. Neurosci.,
September 14, 2005;
25(37):
8555 - 8566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Coggan, T. M. Bartol, E. Esquenazi, J. R. Stiles, S. Lamont, M. E. Martone, D. K. Berg, M. H. Ellisman, and T. J. Sejnowski
Evidence for Ectopic Neurotransmission at a Neuronal Synapse
Science,
July 15, 2005;
309(5733):
446 - 451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Deck, S. Bibevski, T. Gnecchi-Ruscone, V. Bellina, N. Montano, and M. E. Dunlap
{alpha}7-Nicotinic acetylcholine receptor subunit is not required for parasympathetic control of the heart in the mouse
Physiol Genomics,
June 16, 2005;
22(1):
86 - 92.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Nai, J. M. McIntosh, and J. F. Margiotta
Relating Neuronal Nicotinic Acetylcholine Receptor Subtypes Defined by Subunit Composition and Channel Function
Mol. Pharmacol.,
February 1, 2003;
63(2):
311 - 324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Brumwell, J. L. Johnson, and M. H. Jacob
Extrasynaptic alpha 7-Nicotinic Acetylcholine Receptor Expression in Developing Neurons Is Regulated by Inputs, Targets, and Activity
J. Neurosci.,
September 15, 2002;
22(18):
8101 - 8109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fucile, E. Palma, A. Martinez-Torres, R. Miledi, and F. Eusebi
The single-channel properties of human acetylcholine alpha 7 receptors are altered by fusing alpha 7 to the green fluorescent protein
PNAS,
March 19, 2002;
99(6):
3956 - 3961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Shoop, E. Esquenazi, N. Yamada, M. H. Ellisman, and D. K. Berg
Ultrastructure of a Somatic Spine Mat for Nicotinic Signaling in Neurons
J. Neurosci.,
February 1, 2002;
22(3):
748 - 756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-s. Liu, H. Kawai, and D. K. Berg
beta -Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons
PNAS,
March 22, 2001;
(2001)
81553598.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. D. Shoop, K. T. Chang, M. H. Ellisman, and D. K. Berg
Synaptically Driven Calcium Transients via Nicotinic Receptors on Somatic Spines
J. Neurosci.,
February 1, 2001;
21(3):
771 - 781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Cameron and S. E. Dryer
BK-Type KCa Channels in Two Parasympathetic Cell Types: Differences in Kinetic Properties and Developmental Expression
J Neurophysiol,
December 1, 2000;
84(6):
2767 - 2776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. McNerney, D. Pardi, P. C. Pugh, Q. Nai, and J. F. Margiotta
Expression and Channel Properties of alpha -Bungarotoxin-Sensitive Acetylcholine Receptors on Chick Ciliary and Choroid Neurons
J Neurophysiol,
September 1, 2000;
84(3):
1314 - 1329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bibevski, Y. Zhou, J. M. McIntosh, R. E. Zigmond, and M. E. Dunlap
Functional Nicotinic Acetylcholine Receptors That Mediate Ganglionic Transmission in Cardiac Parasympathetic Neurons
J. Neurosci.,
July 1, 2000;
20(13):
5076 - 5082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Shoop, N. Yamada, and D. K. Berg
Cytoskeletal Links of Neuronal Acetylcholine Receptors Containing alpha 7 Subunits
J. Neurosci.,
June 1, 2000;
20(11):
4021 - 4029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Temburni, R. C Blitzblau, and M. H Jacob
Receptor targeting and heterogeneity at interneuronal nicotinic cholinergic synapses in vivo
J. Physiol.,
May 15, 2000;
525(1):
21 - 29.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Whiteaker, J. M. McIntosh, S. Luo, A. C. Collins, and M. J. Marks
125I-alpha -Conotoxin MII Identifies a Novel Nicotinic Acetylcholine Receptor Population in Mouse Brain
Mol. Pharmacol.,
May 1, 2000;
57(5):
913 - 925.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Figl and B. N Cohen
The {beta} subunit dominates the relaxation kinetics of heteromeric neuronal nicotinic receptors
J. Physiol.,
May 1, 2000;
524(3):
685 - 699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-s. Liu and D. K. Berg
Actin Filaments and the Opposing Actions of CaM Kinase II and Calcineurin in Regulating alpha 7-Containing Nicotinic Receptors on Chick Ciliary Ganglion Neurons
J. Neurosci.,
December 1, 1999;
19(23):
10280 - 10288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-S. Liu and D. K. Berg
Extracellular Calcium Regulates Responses of Both alpha 3- and alpha 7-Containing Nicotinic Receptors on Chick Ciliary Ganglion Neurons
J Neurophysiol,
September 1, 1999;
82(3):
1124 - 1132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. Chang and D. K. Berg
Nicotinic Acetylcholine Receptors Containing alpha 7 Subunits Are Required for Reliable Synaptic Transmission In Situ
J. Neurosci.,
May 15, 1999;
19(10):
3701 - 3710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E Nelson and J. Lindstrom
Single channel properties of human {alpha}3 AChRs: impact of {beta}2, {beta}4 and {alpha}5 subunits
J. Physiol.,
May 1, 1999;
516(3):
657 - 678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Obaid, T. Koyano, J. Lindstrom, T. Sakai, and B. M. Salzberg
Spatiotemporal Patterns of Activity in an Intact Mammalian Network with Single-Cell Resolution: Optical Studies of Nicotinic Activity in an Enteric Plexus
J. Neurosci.,
April 15, 1999;
19(8):
3073 - 3093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Shoop, M. E. Martone, N. Yamada, M. H. Ellisman, and D. K. Berg
Neuronal Acetylcholine Receptors with alpha 7 Subunits Are Concentrated on Somatic Spines for Synaptic Signaling in Embryonic Chick Ciliary Ganglia
J. Neurosci.,
January 15, 1999;
19(2):
692 - 704.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Blumenthal, R. D. Shoop, and D. K. Berg
Developmental Changes in the Nicotinic Responses of Ciliary Ganglion Neurons
J Neurophysiol,
January 1, 1999;
81(1):
111 - 120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Cuevas and D. K. Berg
Mammalian Nicotinic Receptors with alpha 7 Subunits That Slowly Desensitize and Rapidly Recover from alpha -Bungarotoxin Blockade
J. Neurosci.,
December 15, 1998;
18(24):
10335 - 10344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Lopez, C. Montiel, C. J. Herrero, E. Garcia-Palomero, I. Mayorgas, J. M. Hernandez-Guijo, M. Villarroya, R. Olivares, L. Gandia, J. M. McIntosh, et al.
Unmasking the functions of the chromaffin cell alpha 7 nicotinic receptor by using short pulses of acetylcholine and selective blockers
PNAS,
November 24, 1998;
95(24):
14184 - 14189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Luo, J. M. Kulak, G. E. Cartier, R. B. Jacobsen, D. Yoshikami, B. M. Olivera, and J. M. McIntosh
alpha -Conotoxin AuIB Selectively Blocks alpha 3beta 4 Nicotinic Acetylcholine Receptors and Nicotine-Evoked Norepinephrine Release
J. Neurosci.,
November 1, 1998;
18(21):
8571 - 8579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Wang, M. E. Nelson, A. Kuryatov, F. Olale, J. Cooper, K. Keyser, and J. Lindstrom
Chronic Nicotine Treatment Up-regulates Human alpha 3beta 2 but Not alpha 3beta 4 Acetylcholine Receptors Stably Transfected in Human Embryonic Kidney Cells
J. Biol. Chem.,
October 30, 1998;
273(44):
28721 - 28732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Frazier, A. V. Buhler, J. L. Weiner, and T. V. Dunwiddie
Synaptic Potentials Mediated via alpha -Bungarotoxin-Sensitive Nicotinic Acetylcholine Receptors in Rat Hippocampal Interneurons
J. Neurosci.,
October 15, 1998;
18(20):
8228 - 8235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Radcliffe and J. A. Dani
Nicotinic Stimulation Produces Multiple Forms of Increased Glutamatergic Synaptic Transmission
J. Neurosci.,
September 15, 1998;
18(18):
7075 - 7083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-s. Liu, H. Kawai, and D. K. Berg
beta -Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons
PNAS,
April 10, 2001;
98(8):
4734 - 4739.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|